Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas

Cancer

Volumn 95, Issue 7, 2002, Pages 1546-1553

  Fukumoto, Shin Ichi ^a   Shirato, Hiroki ^a   Shimzu, Shinichi ^a   Ogura, Shigeaki ^a   Onimaru, Rikiya ^a   Kitamura, Kei ^a   Yamazaki, Koichi ^a   Miyasaka, Kazuo ^a   Nishimura, Masaharu ^a   Dosaka Akita, Hirotoshi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Image guided radiotherapy; Nonsmall cell lung carcinomas (NSCLC); Pulmonary function; Radiation pneumonitis

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MALE; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036785415     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10853     Document Type: Article

References (31)

1. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiotherapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with ≧69.6 Gy in favourable patients with Radiation Therapy Oncology Group Stage III non-small cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 1990;8:1543-1555.
2. Haffty BG. Is radiation therapy a viable alternative to surgery in early stage lung cancer? Int J Radiat Oncol Biol Phys. 1990;19:223-224.
3. Sandler HM, Curran WJ, Turrisi AT 3rd. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1990;19:9-13.
4. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr., Green MR. Improved survival in stage III non-small cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210-1215.
5. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst. 1991;83:417-423.
6. Sause WT, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst. 1995;87:198-205.
7. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109-122.
8. Kihlstrom L, Karlsson B, Lindqvist C. Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years' experience. Stereotact Funct Neurosurg. 1993;61:45-50.
9. Flickinger JC, Kondoziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994;28:797-802.
10. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol. 1995;34:861-870.
11. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer. 1998;82:1062-1070.
12. Arimoto T, Usubuchi H, Matsuzawa T, et al. Small volume multiple non-coplanar arc radiotherapy (SMART) for tumors of the lung, head and neck and the abdominopelvic region. In: Lemke HU, Vannier MW, Inaumra K, Farman A, editors. Computer assisted radiology and surgery '98.). Amsterdam: Elsevier Science, 1998:257-259.
13. Sobin LH, Wittekind C, eds. UICC TNM classification of malignant tumors, 5th ed. New York: John Wiley, 1997.
14. Travis WD, Colby TV, Corrin B, Shimosato Y. Histological classification of lung and pleural tumors. In: Travis WD, Colby TV, Corrin B, Shimosato Y. Histological typing of lung and pleural tumors, 3rd ed. Heidelberg: Springer-Verlag, 1999:21-66.
15. LENT-SOMA Tables. Radiother Oncol. 1995;35:17-60.
16. Arimoto T, Takamura A, Tomita M, Suzuki K, Hosokawa M, Kaneko Y. Intraoperative radiotherapy for esophageal carcinoma - significance of IORT dose for the incidence of fatal tracheal complication. Int J Radiat Oncol Biol Phys. 1993;27:1063-1067.
17. Shirato H, Takamura A, Tomita M, et al. Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys. 1997;37:385-391.
18. Sakamoto S, Arimoto T. Spatial parameters and the organ tolerance in stereotactic multiple arc radiotherapy: JASTRO research group report. J Jastro. 1998;10:153-160.
19. Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys. 2000;48:449-457.
20. Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncol. 1994;33:677-683.
21. Sato M, Uematsu M, Yamamoto F. Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurg. 1998;1:233-238.
22. Ohara K, Okumura T, Akisada M, et al. Irradiation synchronized with respiration gate. Int J Radiat Oncol Biol Phys. 1989;17:853-857.
23. Shimizu S, Shirato H, Kagei K, et al. Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46:1127-1133.
24. Tada T, Minakuchi K, Fujioka T, et al. Lung cancer: intermittent irradiation synchronized with respiratory motionresults of a pilot study. Radiology. 1998;207:779-783.
25. Shirato H, Shimizu S, Kunieda T, et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1187-1195.
26. Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53:822-34.
27. Marks LB, Munley MT, Spencer DP, et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys. 1997;38:399-409.
28. Armstrong J, Raben A, Zelefsky M, et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 1997;44:17-22.
29. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncl Biol Phys. 1999;45:323-329.
30. Sunyach MP, Falchero L, Pommier P, et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2000;48:459-463.
31. Fan M, Marks LB, Hollis D, et al. Can we predict radiationinduced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol. 2001;19:543-550.